Foreign vaccine suppliers want protection from potential lawsuits against adverse side effects, but analysts say India is in a better position to bargain now that the second wave is receding, domestic supply is rising and new vaccines are hitting the marketPfizer says won’t make exception for India in its global approach for vaccine supply
Foreign vaccine suppliers want protection from potential lawsuits against adverse side effects, but analysts say India is in a better position to bargain now that the second wave is receding, domestic supply is rising and new vaccines are hitting the market
Subscribe to:
Post Comments (Atom)
-
"The (latest) investment will be used to grow the mobile esports format and establish presence in select overseas markets through its ...
-
The NCLT#39;s Ahmedabad bench has directed the RP to include GAIL in the list of creditors for both the companies.
-
Huawei faces international scrutiny over its ties with the Chinese government and suspicion that Beijing could use Huawei#39;s technology f...
No comments:
Post a Comment